BROADWAY is a clinical research study evaluating the safety and effectiveness of an investigational drug designed to lower cholesterol, specifically low-density lipoprotein cholesterol (LDL-C), known as the harmful or “bad” form of cholesterol.
You may qualify for this study if you:
Are 18 years of age or older
Have a history of Atherosclerotic Cardiovascular Disease (ASCVD) or have been diagnosed with Heterozygous Familial Hypercholesterolemia (HeFH)
Are on a maximally tolerated lipid-modifying therapy
Have a historical LDL ≥ 55 mg/dL
Compensation up to $375 may be provided for your time and travel.